Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
General transcription factor IIi pseudogene 13 (GTF2IP13)
- Target
- GTF2IP13
- Molecular classification
- Pseudogene
01
Overview
GTF2IP13, or General transcription factor IIi pseudogene 13, is a genomic pseudogene related to the functional gene GTF2I, which encodes the transcription factor TFII-I. Pseudogenes typically do not produce functional proteins and are generally not considered relevant for physiological processes, therapeutic targeting, or disease mechanisms. No notable biological function, therapeutic significance, or disease association is reported for GTF2IP13 in current biomedical literature or genomic databases[5].
- Other names
- GTF2I pseudogene 13GTF2IP13
Beyond the preview
Go deeper on General transcription factor IIi pseudogene 13 (GTF2IP13).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on General transcription factor IIi pseudogene 13 (GTF2IP13).